Skip to NavigationSkip to content

News

AstraZeneca has confirmed that its PARP inhibitor Lynparza (olaparib) has been awarded orphan drug designation in Japan for the maintenance...
The European Medicines Agency (EMA) has called on the European Union to collaborate closely on carrying out clinical trials on treatments and...
Novartis has revealed that its gene therapy Zolgensma (onasemnogene abeparvovec) has secured approval from Japan’s Ministry of Health, Labour and...
New research shows that the COVID-19 coronavirus is stable for hours to days in aerosols and on surfaces.
The National Institute for Health and Care Excellence (NICE) and the European Medicines Regulatory have both stated that there is currently no...
Total global spending on medicines is set to break $1.1 trillion by 2024, a new report released by IQVIA has asserted, rising from $935 billion in...
A flu drug has appeared to be effective in treating COVID-19, according to recent clinical trials in China.
It is now known that around 100 of the known cases of the COVID-19 coronavirus can be traced to an event held in Boston, Massachusetts by major...
The $63 billion merger of major pharma players AbbVie and Allergan could be facing hurdles on the road to regulatory sign-off as the ongoing COVID-...
NICE, the drug watchdog for the NHS in England and Wales, has announced that it has promoted Professor Gillian Leng to serve as its new Chief...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches